No Data
No Data
Press Release: Apotex Receives Investment Grade Issuer Rating From Morningstar DBRS and Announces Amended & Restated Credit Agreement
Apotex Receives Investment Grade Issuer Rating From Morningstar DBRS And Announces Amended & Restated Credit Agreement >APTX.T
Canaccord Genuity Initiates Coverage On Apotex Health With Buy Rating, Announces Price Target of C$42
Apotex Health Corp. Price Target Announced at C$42.00/Share by Canaccord Genuity
Apotex Health Corp Price Target Raised to C$43.00/Share From C$39.00 by BMO Capital Markets
Fine, Kaplan and Black, R.P.C. Anuncia Que Ya Se Aceptan Formularios De Reclamación Para Los Acuerdos De Demanda Colectiva Si Pagó O Recibió Un Reembolso Por Determinados Medicamentos Genéricos Recetados En Estados Unidos Entre El 1 De Mayo De...